
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation and Psilocybin in the Treatment of Depression. A Review
Kristin Heuschkel, Kim P. C. Kuypers
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 74
Kristin Heuschkel, Kim P. C. Kuypers
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 74
Showing 1-25 of 74 citing articles:
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Lily R. Aleksandrova, Anthony G. Phillips
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 11, pp. 929-942
Closed Access | Times Cited: 161
Lily R. Aleksandrova, Anthony G. Phillips
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 11, pp. 929-942
Closed Access | Times Cited: 161
Combining Psychedelic and Mindfulness Interventions: Synergies to Inform Clinical Practice
Jake Payne, Richard Chambers, Paul Liknaitzky
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 416-423
Open Access | Times Cited: 66
Jake Payne, Richard Chambers, Paul Liknaitzky
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 2, pp. 416-423
Open Access | Times Cited: 66
Neural Mechanisms and Psychology of Psychedelic Ego Dissolution
Devon Stoliker, Gary F. Egan, Karl Friston, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 876-917
Open Access | Times Cited: 54
Devon Stoliker, Gary F. Egan, Karl Friston, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 4, pp. 876-917
Open Access | Times Cited: 54
The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review
Andrew Hodge, Suporn Sukpraprut‐Braaten, Matthew R Narlesky, et al.
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 1, pp. 40-50
Closed Access | Times Cited: 39
Andrew Hodge, Suporn Sukpraprut‐Braaten, Matthew R Narlesky, et al.
Journal of Psychoactive Drugs (2022) Vol. 55, Iss. 1, pp. 40-50
Closed Access | Times Cited: 39
From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders
Urszula Kozłowska, Charles D. Nichols, Kalina Wiatr, et al.
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 89-108
Open Access | Times Cited: 51
Urszula Kozłowska, Charles D. Nichols, Kalina Wiatr, et al.
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 89-108
Open Access | Times Cited: 51
Psychedelic unselfing: self-transcendence and change of values in psychedelic experiences
Juuso Kähönen
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 17
Juuso Kähönen
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 17
Mindfulness meditation and psychedelics: potential synergies and commonalities
Paweł Holas, Justyna Kamińska
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1398-1409
Open Access | Times Cited: 16
Paweł Holas, Justyna Kamińska
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1398-1409
Open Access | Times Cited: 16
Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation
Berit Singer, Daniel Meling, Matthias Hirsch‐Hoffmann, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Berit Singer, Daniel Meling, Matthias Hirsch‐Hoffmann, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals
Anna Søndergaard, M. Madsen, Brice Ozenne, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 23
Anna Søndergaard, M. Madsen, Brice Ozenne, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 23
Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review
Shawn Ziff, Benjamin Stern, Gregory D. Lewis, et al.
Cureus (2022)
Open Access | Times Cited: 22
Shawn Ziff, Benjamin Stern, Gregory D. Lewis, et al.
Cureus (2022)
Open Access | Times Cited: 22
Psilocybin’s effects on cognition and creativity: A scoping review
Justin N Bonnieux, Baeleigh VanderZwaag, Zahra Premji, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 635-648
Open Access | Times Cited: 15
Justin N Bonnieux, Baeleigh VanderZwaag, Zahra Premji, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 635-648
Open Access | Times Cited: 15
The effect of psilocybin on empathy and prosocial behavior: a proposed mechanism for enduring antidepressant effects
Kush Bhatt, Cory R. Weissman
npj Mental Health Research (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 4
Kush Bhatt, Cory R. Weissman
npj Mental Health Research (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 4
Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial
Benjamin R. Lewis, John Hendrick, Kevin Byrne, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Benjamin R. Lewis, John Hendrick, Kevin Byrne, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The Network Relationship Between the Core Elements of Interpersonal Communication Competence and Depression in Chinese College Students
XiaoShuang Li, Ma Agatha Anne D Guintu
Cureus (2025)
Open Access
XiaoShuang Li, Ma Agatha Anne D Guintu
Cureus (2025)
Open Access
Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study
Mathias E. Jensen, Dea Siggaard Stenbæk, Catharina Messell, et al.
Journal of Psychopharmacology (2025)
Open Access
Mathias E. Jensen, Dea Siggaard Stenbæk, Catharina Messell, et al.
Journal of Psychopharmacology (2025)
Open Access
A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress
Fejzic Dino
Cureus (2025)
Open Access
Fejzic Dino
Cureus (2025)
Open Access
Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy
Maria Eleni Eleftheriou, Emily M Thomas
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 30
Maria Eleni Eleftheriou, Emily M Thomas
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 30
Psychedelic Experience
Aidan Lyon
Oxford University Press eBooks (2023)
Closed Access | Times Cited: 12
Aidan Lyon
Oxford University Press eBooks (2023)
Closed Access | Times Cited: 12
Classic Psychedelic Use and Current Meditation Practice
Charlotta Simonsson, Richard Chambers, Peter S. Hendricks, et al.
Mindfulness (2023) Vol. 14, Iss. 4, pp. 763-768
Open Access | Times Cited: 11
Charlotta Simonsson, Richard Chambers, Peter S. Hendricks, et al.
Mindfulness (2023) Vol. 14, Iss. 4, pp. 763-768
Open Access | Times Cited: 11
Scutellarin protects against lipopolysaccharide-induced behavioral deficits by inhibiting neuroinflammation and microglia activation in rats
Hetao Bian, Gaohua Wang, Junjie Huang, et al.
International Immunopharmacology (2020) Vol. 88, pp. 106943-106943
Closed Access | Times Cited: 28
Hetao Bian, Gaohua Wang, Junjie Huang, et al.
International Immunopharmacology (2020) Vol. 88, pp. 106943-106943
Closed Access | Times Cited: 28
Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies
Halsey Niles, Colleen Fogg, Ben Kelmendi, et al.
BMC Palliative Care (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 26
Halsey Niles, Colleen Fogg, Ben Kelmendi, et al.
BMC Palliative Care (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 26
Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors
Robertas Strumila, Bénédicte Nobile, Laura Korsakova, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1213-1213
Open Access | Times Cited: 23
Robertas Strumila, Bénédicte Nobile, Laura Korsakova, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 12, pp. 1213-1213
Open Access | Times Cited: 23
Psychedelics in the treatment of unipolar and bipolar depression
Oliver G. Bosch, Simon Halm, Erich Seifritz
International Journal of Bipolar Disorders (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 18
Oliver G. Bosch, Simon Halm, Erich Seifritz
International Journal of Bipolar Disorders (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 18
A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development
Henry J. Whitfield
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 20
Henry J. Whitfield
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 20
Potential Therapeutic Effects of Psilocybin: A Systematic Review
Dev B Goel, Sarju Zilate
Cureus (2022)
Open Access | Times Cited: 13
Dev B Goel, Sarju Zilate
Cureus (2022)
Open Access | Times Cited: 13